AZN (AstraZeneca) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AZN AstraZeneca PLC AZN
77 GF Score
Price $168.58
GF Value $180.57
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is AstraZeneca Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

AZN
77GF Score
AstraZeneca PLC AZN
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AstraZeneca (AZN) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be undervalued. The current stock price of $168.58 is trading 6.6% below its estimated GF Value™ of $180.57. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for AZN:

  • Dividend-Payout-to-FFO:
  • GF Value™: $180.57 vs. price of $168.58 (6.6% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the AZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
77GF Score

Get the complete analysis for AZN

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$168.58
Price
$180.57
GF Value